Coronary surgery in patients with diabetes mellitus: a risk-adjusted study on early outcome by Antunes, PE et al.
Coronary surgery in patients with diabetes mellitus:
a risk-adjusted study on early outcome
Pedro E. Antunes, J. Ferra˜o de Oliveira, Manuel J. Antunes *
Cardiothoracic Surgery, University Hospital, Coimbra, Portugal
Received 28 January 2008; received in revised form 5 May 2008; accepted 9 May 2008; Available online 9 June 2008
Abstract
Objectives:We aimed at determining the effect of diabetes mellitus (diabetes) on short-term mortality and morbidity in a cohort of patients
with ischemic disease undergoing coronary artery bypass surgery (CABG) at our institution. Material and methods: A total of 4567 patients
undergoing isolated CABG in a 10-year periodwere studied. Diabetesmellitus was present in 22.6% of the cases but the percentage increased from
19.1% in the beginning to 27% in the end of the study period ( p < 0.0001 for the decade time-trend). Compared with non-diabetic patients, the
group with diabetes was older (61.5  8.4 years vs 60.4  9.5 years), had a higher body mass index (26.4  2.2 vs 26.0  2.2), comprised more
women (17.5% vs 10.1%), and had a greater incidence of peripheral vascular disease (13.3% vs 8.8%), cerebrovascular disease (8.3% vs 4.3%), renal
failure (2.7% vs 1.1%), cardiomegaly (14.0% vs 10.9%), class III—IVangina (43.4% vs 39.0%), triple-vessel disease (80.9% vs 73.7%) and patients with
left ventricular dysfunction (all p < 0.05). Demographic and peri-procedural data were registered prospectively in a computerized institutional
database. Multivariate logistic regression was performed to assess the influence of diabetes as an independent risk factor for in-hospital mortality
and morbidity. Results: The overall in-hospital mortality was 0.96% [n = 44; diabetics: 1.0%, non-diabetics: 0.9% ( p = 0.74)]. The mortality of
patients with diabetes decreased from 2.7% in the early period to 0.7% in the late period (p = 0.03 for the time-trend). Postoperative in-hospital
complications were comparable in the two groups in univariate analysis, with only cerebrovascular accident and prolonged length of stay being
significantly higher in the diabetic patients (all p < 0.05). In multivariate analysis, diabetes was not found to be an independent risk factor for in-
hospital mortality (OR = 0.61; 95% CI = 0.28—1.30; p = 0.19), but predicted the occurrence of mediastinitis (OR = 1.80; 95% CI = 1.01—3.22;
p = 0.049). Conclusions: Despite worse demographic and clinical characteristics, diabetic patients could be surgically revascularized with low
mortality and morbidity, comparable with control patients. Hence, our data do not support diabetes as a risk factor for significantly adverse early
outcome following CABG.
# 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Diabetes mellitus is most often recognized as a risk factor
for adverse outcomes after coronary artery bypass graft
surgery (CABG), with regard to both early postoperative
results and long-term survival [1—4]. Hence, there is a need
for continuously evaluating the performance of surgical
revascularization in diabetic patients, because (1) diabetes is
present in approximately one-quarter of the patients
undergoing CABG [1,3,5,6], and its prevalence is steadily
increasing [7,8]; and (2) over the years, several reports have
attested the superiority of CABG over percutaneous coronary
intervention for coronary revascularization in diabetic
patients [9—12].* Corresponding author. Address: Cirurgia Cardiotora´cica, Hospitais da Uni-
versidade, 3000-075 Coimbra, Portugal. Tel.: +351 239400418;
fax: +351 239829674.
E-mail address: antunes.cct.huc@sapo.pt (M.J. Antunes).
1010-7940/$ — see front matter # 2008 European Association for Cardio-Thoracic S
doi:10.1016/j.ejcts.2008.05.008However, the impact of diabetes in the short-term
mortality and morbidity in patients undergoing CABG is
unclear and remains a subject of debate. While some studies
reported a significant negative influence of diabetes in early
postoperative outcomes [2,5], others have even suggested a
better outcome in this group of patients [1,3,4].
In this report we assess the impact of diabetes in the early
mortality and morbidity in a large series of patients
subjected to CABG in a single institution, adjusting for
patient and disease characteristics.2. Materials and methods
2.1. Study design and population
We performed a retrospective study of patients who
underwent CABG during a 10-year period at our institution.
All patients undergoing isolated first operations and reopera-urgery. Published by Elsevier B.V. All rights reserved.
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heart valve repair or replacement, resection of a ventricular
aneurysm, or other surgical procedures were excluded. All
operations were performed without cardioplegia, under
hypothermic ventricular fibrillation or empty beating heart,
a technique described in detail in a previous report from our
group [13].
2.2. Study variables and definitions
The study included the following preoperative, operative

































areoperative: age; body mass index; gender; hyperten-
sion; dyslipidemia; recent smoking; peripheral vascular
disease; cerebrovascular disease; renal failure; anemia;
chronic obstructive pulmonary disease; cardiomegaly;
previous myocardial infarction; recent myocardial
infarction; unstable angina; Canadian Cardiovascular
Society (CCS) class; non-elective surgery; previous
percutaneous coronary intervention (PCI); prior CABG;
ejection fraction; left ventricular dysfunction; left main
disease; and extent of coronary disease (1—2 vessel or 3
vessel). Definitions of these variables are presented in
Appendix A.1
graphic and clinical characteristics (n = 4567)
ble Diabetic (N = 1030) % (22.6)
age (years) 61.52  8.41
body mass index 26.39  2.22
le sex 180 17.5
rtension 612 59.4
pidemia 668 64.9
nt smoking 87 8.4
heral vascular disease 158 13.3
brovascular disease 85 8.3




ous myocardial infarction 588 57.1
nt myocardial infarction 57 5.5




ous PCI 46 4.5
CABG 20 1.9
main disease 181 17.6






t of coronary disease
2 vessel 197 19.1
essel 833 80.9
n = 2481; 553 diabetic and 1928 non-diabetic patients.(2) Operative: number and type of grafts, the use of
coronary endarterectomy and the cardiopulmonary
bypass (CPB) time.(3) Outcome variables: in-hospital mortality and the follow-
ing postoperative complications: cerebrovascular acci-
dent, mediastinitis, acute renal failure, reoperation for
bleeding, myocardial infarction, atrial and ventricular
arrhythmias, inotropic support, mechanical support, and
prolonged length of stay.Definitions of these complications are presented in
Appendix B.
Diabetes was defined as a history of the disease and the
patient currently receiving treatment with either oral
medications or insulin. In-hospital mortality was defined as
death during hospital stay, unlimited in time.
2.3. Data collection
Data were collected prospectively on a standardized
written form by the involved surgeon and validated and
inputted in a computerized database by the first author. Data
collection and storage was supervised by the project
coordinator (MJA) for consistency, and aggregate outputs
were periodically crosschecked against an independentNon-diabetic (N = 3537) % (77.4) p value
60.39  9.46 0.001
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Table 2
Operative data
Variable Diabetic (N = 1030) % (22.6) Non-diabetic (N = 3537) % (77.4) p value
N of distal anastomoses per patient (mean  SD)
Total 2.88  0.79 2.80  0.81 0.005
Arterial 1.15  0.41 1.28  0.49 <0.001
LIMA use 1021 99.1 3517 99.4 0.55
RIMA use 136 13.2 934 26.4 <0.001
BIMA use 134 12.6 896 25.6 <0.001
Coronary endarterectomy 86 8.3 238 6.7 0.075
CPB time, mean  SD (min) 62.8  19.9 63.0  24.3 0.80clinical database. The data collection instruments included
questions regarding demographic characteristics, preopera-
tive risk factors, previous interventions, preoperative
cardiac status, cardiac catheterization results, intraopera-
tive management and postoperative complications.
2.4. Patient and operative data
The study cohort included 4567 patients undergoing
isolated CABG surgery. Of these, 1030 (22.6%) patients were
classified as diabetic using the definition indicated above.
The percentage of patients with diabetes increased from
19.1% in the early to 27% in the late period ( p < 0.001 for the
decade time-trend).
The distribution of baseline characteristics between the
two groups is shown in Table 1. Comparing with the non-
diabetic, the diabetic group was characterized by a higher
mean age, a higher mean body mass index, a higher
proportion of females and of patients with dyslipidemia,
anemia, cardiomegaly, renal failure, peripheral vascular
disease, cerebrovascular disease, severe angina (CCS class
III—IV), triple-vessel disease and left ventricular dysfunction
(ejection fraction <40%).
The distribution of operative variables is shown in Table 2.
The number of distal anastomoses per patientwas significantly
higher in thediabetic group (2.9 0.8 vs2.8  0.8;p = 0.005).
Although thegroupofdiabeticpatients received fewerarterial
grafts, similar percentages of patients in the two groups were
revascularized with LIMA grafts, in both cases as a conse-
quence of the protocol implemented in these patients.
2.5. Perioperative glycemic control
We aimed at maintaining the blood glucose levels in
diabetic patients between 120 and 160 mg/dl. Preopera-Table 3
Postoperative outcomes
Variable Diabetic (N = 1030) % (22.6)
In-hospital deaths 9 0.9
Cerebrovascular accident 37 3.6
Mediastinitis 18 1.7
Myocardial infarction 32 3.1
Renal dysfunction 28 5.2
Inotropic support 88 8.5
Mechanical support 10 1.0
Reoperation for bleeding 27 2.6
Atrial arrhythmias 246 23.9
Prolonged length of stay 109 10.6tively, diabetic patients were started on a standard sliding
scale subcutaneous insulin injection. In the operating room
and in the ICU they received continuous intravenous insulin
infusions. They were then switched back to the sliding scale
subcutaneous insulin injection until discharge, even after the
resumption of their preoperative glucose control regimen.
For non-diabetic patients, the use of sliding scale insulin
infusion was triggered by blood glucose levels greater than
180 mg/dl.
2.6. Statistical methods
Normally distributed continuous variables are repre-
sented as mean  standard deviation (SD) or as the
percentage of the sample. The x2-test and Fisher’s exact
test were used to determine differences in patient
characteristics by univariate analysis. Multivariate logistic
regression was performed to assess the influence of diabetes
as an independent risk factor for hospital mortality and
postoperative morbidity. Variables included in the adjusted
analyses were chosen because they showed imbalance
between the two groups and/or they were thought to affect
the outcome. The same variables were included in the entire
risk-adjusted analyses presented (see Table 4 footnote for
details). Taken into consideration the presence of a small
effective simple size on the outcome death (n = 44), the
entire database was initially used to develop the predictive
logistic model. Survivors and non-survivors were compared by
univariate analysis. Variables with a p value less than 0.2 by
univariate analysis were used as independent variables in a
stepwise logistic regression analysis, with in-hospital mor-
tality as the binary dependent variable. Because of the
relatively small effective sample size, a p value less than 0.1
was selected for variable retention in the final regression
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Table 4
Risk-adjusted analysis of the effect of diabetes on clinical outcomes
Outcome Adjusteda effect size
Odds ratio 95% confidence interval p value
In-hospital death 0.61 0.28—1.30 0.19
Cerebrovascular accident 1.27 0.84—1.92 0.26
Mediastinitis 1.80 1.01—3.22 0.049
Myocardial infarction 0.93 0.62—1.39 0.71
Renal dysfunction 0.83 0.53—1.29 0.40
Inotropic support 1.01 0.83—1.43 0.53
Mechanical support 1.05 0.47—2.13 0.99
Reoperation for bleeding 1.01 0.65—1.59 0.96
Atrial arrhythmias 0.90 0.76—1.06 0.20
Prolonged length of stay 1.20 0.94—1.52 0.14
a Adjusted for age, sex, body mass index, Canadian Cardiovascular Society
class, previous myocardial infarction, anemia, dyslipidemia, recent smoking,
cardiomegaly, peripheral vascular disease, cerebrovascular disease, prior
CABG, ejection fraction, non-elective surgery, hypertension, and extent of
coronary disease.
Table 5
Predictors of in-hospital mortality in the total population
Variable p value Odds ratio 95% CI (OR)
Age (per 1-year increase) 0.006 1.054 1.015 1.094
Peripheral vascular disease <0.001 4.831 2.590 9.010
LV dysfunction (EF < 40%) 0.055 1.989 0.985 4.016
Non-elective surgery 0.002 3.323 1.556 7.097
Reoperation 0.009 5.040 1.486 17.090logistic regression analysis to select the final set of risk
factors included in the model. In the bootstrap procedure,
200 samples of 4567 patients (the same number of
observations as the original database) were sampled with
replacement. A stepwise logistic regression analysis was
applied to every bootstrap sample. If the predictors occurred
in more than 50% of the bootstrap models, they were judged
to be reliable and were retained in the final model.
Unreliable variables, if present, were removed from the
final model.
The statistical significance of time-trends, prevalence of
diabetes and in-hospital mortality during the 10-year period
was determined by logistic regression. A p value <0.05 was
considered significant for all tests.3. Results
Postoperative outcomes are shown in Table 3. The overall
in-hospital mortality was 0.96% (n = 44). There was no
difference in the mortality rate of the diabetic and non-
diabetic groups (0.9% and 1.0%, respectively; p = 0.74). The
mortality of patients with diabetes decreased from 2.7% in
the early period to 0.7% in the late period ( p = 0.03 for the
decade time-trend).
Table 4 shows the influence of diabetes on the mortality
and postoperative morbidity after adjustment for potential
confounders. The presence of diabetes was not found to be
an independent predictor of in-hospital mortality on multi-
variate analysis (OR = 0.61; 95% CI 0.28—1.30; p = 0.19)
(Table 4). By contrast, age (increasing), reoperation,
peripheral vascular disease, left ventricular dysfunction
(ejection fraction <40%) and non-elective surgery were
identified as independent predictors of in-hospital death
(Table 5).
In-hospital morbidity events were mostly comparable in
the two groups by univariate analysis, with only cerebro-
vascular accident and prolonged length of stay showing a
significantly higher incidence in the diabetic patients.
Requirement for inotropic support ( p = 0.074) and medias-
tinitis ( p = 0.084) approached statistical significance. How-
ever, by multivariate analysis, diabetes had an independentinfluence only in the development of mediastinitis
(OR = 1.80; 95% CI 1.01—3.22; p = 0.049), whereas the
association with cerebrovascular accident ( p = 0.26) and
prolonged length of stay ( p = 0.14) disappeared.4. Discussion
Most reports indicate that diabetes is present in
approximately one-quarter of the patients undergoing
revascularization for coronary artery disease, for which it
is considered a risk factor [1,3,5,6], but there has been a
steady increase in the incidence. Analysis of the data from
the Society of Thoracic Surgeons National Adult Cardiac
Database and from the Society of Cardiothoracic Surgeons of
Great Britain and Ireland showed an increase in the
prevalence of diabetes in patients referred for CABG (21%
in 1990 to 33% in 1999, and 18% in 1994 to 23.5% in 2001,
respectively) [7,8]. In our contemporary series, we observed
a similar percentage of diabetic patients referred for CABG
with an overall prevalence of 22.6% and a significant increase
in the prevalence of diabetes, from 19.1% in the beginning to
27% in the end ( p < 0.0001 for the decade time-trend).
Our diabetic patients had a similar preoperative higher
risk profile as patients from other reported series [1,3—6].
Patients with diabetes were more likely to be older and
female, and to have a higher mean body mass index, severe
angina, peripheral vascular disease, cerebrovascular disease,
renal failure, anemia, dyslipidemia, cardiomegaly, triple-
vessel disease, as well as a decreased LVejection fraction, all
factors which are well known for their negative impact on
outcome.
It is generally accepted that diabetic individuals sub-
jected to CABG have a higher early mortality, but the
influence of diabetes per se on this outcome has been under
debate. In the study reported by Thourani et al. [2], the
mortality was significantly higher among the diabetic (3.9%)
compared to the non-diabetic population (1.6%). The North
American Multicenter Registry data of 146,786 patients who
underwent CABG surgery in 1997 indicates a 30-day mortality
of 3.7% in diabetic patients compared to 2.7% in non-diabetic
patients [5]. In both studies, diabetes was found to be an
independent predictor of early (in-hospital or 30-day)
mortality. However, more recent studies have challenged
these findings by reporting more favorable results, crude and
adjusted, in diabetic patients undergoing CABG. Szabo et al.
[1], Rajakaruna et al. [3] and Filsoufi et al. [4] reported
mortality rates of 2.6%, 2.2% and 2.4%, respectively, in
diabetic patients and did not isolate diabetes as an
independent predictor of early mortality. Our in-hospital
mortality for diabetic patients was 1.0%, only marginally
higher that in non-diabetics (0.9%) and we could also not
P.E. Antunes et al. / European Journal of Cardio-thoracic Surgery 34 (2008) 370—375374identify diabetes as an independent predictor of early
mortality. This could be related to the small number of events
(44 deaths) in the series. Although there is no consensus on
sample size, as a rule of thumb in studies deriving
multivariable prognostic models, 10 or more events per
variable are usually required in order to get a robust
estimation of the coefficients. The ratio of events to risk
factors included in our local model presented in Table 5 was
approximately 9—1 (44 events; 5 variables), therefore, the
data of the multivariate analysis should be interpreted with
caution.
There is now clear evidence that the impact of diabetes on
in-hospital mortality has changed over time. According to the
Society of Cardiothoracic Surgeons of Great Britain and
Ireland, in 1997 diabetic patients were twice as likely to die
after CABG compared to non-diabetics (5.9% vs 3.0%), but by
2001 there had been an important reduction in the operative
mortality (2.9% vs 2.2%), practically eliminating diabetes as
an additional risk [7]. In the study reported by Filsoufi et al.
[4], the mortality rate among diabetics decreased signifi-
cantly, from 3.1% in the period 1998—2002 to 1.0% in 2003—
2005. Similarly, our study shows a decrease in in-hospital
mortality among diabetic patients over the decade in analysis
from 2.7% in 1992 to 0.7% in 2001 ( p = 0.03 for the decade
time-trend). Better knowledge of the pathophysiology and
improved pre- and perioperative control of the disease may
have contributed to this evolution.
In this series, the incidences of morbidity events analyzed
were also similar in the two groups by univariate analysis,
with only cerebrovascular accident and prolonged length of
stay showing a significantly higher incidence in diabetic
patients. However, by multivariate analysis, diabetes had
only an independent influence on the development of
mediastinitis (OR = 1.80). The studies reported by Filsoufi
et al. [4], Kubal et al. [14] and Shroyer et al. [15] also
demonstrated that diabetes had an independent influence on
the development of sternal infection.
The independent influence of diabetes in the develop-
ment of a cerebrovascular accident has been described by
some authors [1,3]. Although univariate analysis had shown a
significantly higher incidence of cerebrovascular accidents in
our diabetic patients, this association disappeared in the
multivariate analysis. This finding is also in accordance with
those of some recent studies [4,14].
In contrast with the previously published studies of Szabo,
Rajakaruna and Kubal and their co-workers [1,3,14], we
could not identify diabetes as an independent predictor of
acute renal failure or prolonged length of stay. Additionally,
diabetes was also not associated with the rate of post-
operative myocardial infarction, with increased requirement
for inotropic or mechanical support, the occurrence of atrial
arrhythmia and need for re-exploration for bleeding in our
patients.
There is now evidence to suggest that a better blood
glucose management in the perioperative period improves
early outcomes in diabetic patients subjected to CABG [16].
Estrada, Fish, Furnary and their co-workers demonstrated
that controlling blood glucose levels at values lower than
200 mg/dl in diabetic patients leads to significantly fewer
postoperative complications, including in-hospital death
[17—19]. During the 10-year study interval in our series,we aimed at maintaining the blood glucose levels between
120 and 160 mg/dl in diabetic patients, and below 180 mg/dl
in non-diabetic patients, during the perioperative period. We
believe that this approach has contributed to the good
surgical outcomes observed in these patients.
There are some limitations in this study, which may affect
its conclusions. This is an observational study and, by its
retrospective nature (although the data was prospectively
collected), it cannot account for the unknown variables
affecting the outcomes that are not correlated strongly with
the variables used in the risk adjustment. However, multi-
variate analysis is a theoretically sound statistical method of
accounting for differences between groups in the absence of
random allocation. Also, this study was based on a large
cohort of patients from a single institution, which adds
strength to the power of the analysis.
In conclusion, despite the worsening case-mix, in our
experience diabetic patients could be surgically revascular-
ized with low mortality and morbidity rates, comparable to
those of non-diabetic patients. Hence, our data do not
support the conclusions by other authors who found diabetes
to be a risk factor for significantly adverse early outcome
following CABG. Better knowledge of the disease and
improved management of blood glucose levels led to a
significant improvement in the results during the study-
period and beyond.
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Appendix A. Definition of preoperative variablesHypertension Blood pressure exceeding
140/90 mmHg, or a history of
high blood pressure, or the
need of antihypertensive medicationsRenal failure Creatinine >2.0 mg/dl and no dialysis
dependencyRecent smoking Up to less than 4 weeks of surgery
Anemia Hematocrit 34%
Cardiomegaly Cardiothoracic ratio >0.50 on a chest
X-ray-film
Pulmonary obstructive
chronic diseasePatient requires pharmacologic therapy
for the treatment of chronic
pulmonary compromise, or patient
has a FEV1 <75% of predicted valuePeripheral vascular
diseaseClaudication either with exertion or
at rest; amputation for arterial
insufficiency; aorto-iliac occlusive
disease reconstruction; peripheral
vascular bypass surgery, angioplasty
or stent; documented abdominal
aorta aneurysm, repair or stent; or
non-invasive carotid test
with >75% occlusionCerebrovascular disease Unresponsive coma >24 h, CVA, or TIA
Recent myocardial infarction <30 days
Unstable angina Preoperative use of iv nitrates until
arrival in the anesthetic room
Left ventricular dysfunction Ejection fraction <40%
Non-elective surgery Urgent or emergent surgeryAppendix B. Definition of postoperative complicationsCerebrovascular
accident (CVA)Global or focal neurological deficit lasting
less (transient ischemic attack) or more
than 24 h (reversible ischemic neurologic
deficit; stroke)Mediastinitis At least one of the following: (1) an organism
isolated from culture of mediastinal tissue
or fluid; (2) evidence of mediastinitis
seen during operation; (3) one of the
following conditions: chest pain, sternal
instability, or fever (>38 8C), in combination
with either purulent discharge from the
mediastinum or an organism isolated from
blood culture or culture of mediastinal drainageMyocardial infarction New Q-wave postoperatively in two or more
contiguous leads of the ECGInotropic support Use of one or more inotropic drugs, for any
length of timeMechanical support Use of intra-aortic balloon pumping or
ventricular assistanceAcute renal failure A postoperative creatinine serum level
2.1 mg/dl plus an increase in the serum
creatinine level 0.9 mg/dl from preoperative
to maximum postoperative values in patients
who had no significant pre-existing renal
disease (creatinine 2.0 mg/dl and no
dialysis-dependenceReoperation for bleeding Bleeding or cardiac tamponade that required
intervention after admission into the ICUProlonged postoperative
length of stay10 days
